Patent US4559228A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4559228A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition and method for the treatment of cancer

Assignee: Individual
•
Filing: 1985-04-02
•
Granted: 1985-12-17
•
Expires: 2005-04-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition useful for the treatment of cancer comprises a colloidal or semi-colloidal suspension of DNA-repressor proteins derived from a finely divided mammal nerve tissue, particularly brain tissue. A method of treating cancer comprises administering to the patient a suitable daily dosage of the above composition, accompanied by the administration of suitable doses of immuno globulin (gamma-globulin), during a period of from 45 to 60 days.

Inventors

  • 👤 Daniel M. de la Torre

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 05:37
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/30

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 104 words
A method of treating adenocarcinoma in human patients which comprises administering to a patient a daily dose of from 0.5 to 10 mg/mg of said adenocarcinoma of an iodine sterilized suspension of finely divided brain tissue derived from a bovine or equine animal for a period of time of from 45 to 60 days, wherein the 45 to 60 day administration cycle is alternated with the administration of a daily dosage of gamma-globulin in an amount sufficient to protect against viral infection for a period of time of about 2 to 3 weeks and further comprising administration of a daily dosage of calcium phosphate.
Claim 2
Independent Claim 104 words
A method of treating adenocarcinoma in human patients which comprises administering to a patient a daily dose of from 0.5 to 10 mg/mg of said adenocarcinoma of an iodine sterilized suspension of finely divided brain tissue derived from a bovine or equine animal for a period of time of from 45 to 60 days, wherein the 45 to 60 day administration cycle is alternated with the administration of a daily dosage of gamma-globulin in an amount sufficient to protect against viral infection for a period of time of about 2 to 3 weeks and further comprising administration of a daily dosage of calcium phosphate.
Claim 3
Dependent Claim 43 words
A method according to claim 1 wherein said brain tissue is sterilized by immersing said brain tissue in a 1:2500 aqeous solution of iodine during a period of time of from 1 to 3 minutes, and then rinsing said tissue with distilled water.
Claim 4
Dependent Claim 18 words
A method according to claim 2 wherein said sterilization is effected prior to comminution of the brain tissue.
Claim 5
Independent Claim 15 words
A method according to claims 1, 2 or 3 wherein said gamma-globulin is horse gamma-globulin.
Claim 6
Dependent Claim 18 words
A method according to claim 4, wherein said daily dosage of gamma-globulin is 10 mg/mg of said adenocarcinoma.
Claim 7
Independent Claim 21 words
A method according to claims 1, 2 or 3 wherein said daily dosage of gamma-globulin is 10 mg/mg of said adenocarcinoma.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-12-16 1989-06-17 1989-12-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-12-16 1993-06-17 1993-12-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-12-16 1997-06-17 1997-12-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag